Nov 7, 2024 7:00 am EST Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update
Oct 24, 2024 7:00 am EDT Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024
Sep 6, 2024 7:00 am EDT Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
Sep 3, 2024 7:00 am EDT Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)
Jul 23, 2024 7:00 am EDT Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
Jul 1, 2024 7:00 am EDT Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)
May 28, 2024 4:30 pm EDT Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia
